Skip to main content
logo
Vera Therapeutics, Inc. (VERA)
NASDAQ: VERA · Real-Time Price · USD
32.89
+0.87 (2.72%)
At close: Aug 7, 2026, 4:00 PM EDT
32.99
+0.10 (0.30%)
After-hours: Aug 7, 2026, 7:34 PM EDT

Vera Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
2,3613,6092,688684538569
Market Cap Growth
92.16%34.27%293.16%27.09%-5.38%-
Enterprise Value
1,8412,9722,102576.67454.58493.79
Last Close Price
32.8950.6442.2915.3819.3526.72

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
4.725.974.666.726.998.17
P/TBV Ratio
4.385.384.056.466.695.16

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.150.130.090.500.370.07
Net Debt / Equity Ratio
-1.04-1.05-1.02-1.05-1.08-1.07
Net Debt / EBITDA Ratio
1.362.023.511.050.912.18
Net Debt / FCF Ratio
1.772.644.321.161.233.15
Quick Ratio
13.2213.3725.267.214.4810.36
Current Ratio
13.6413.6425.677.714.9110.73
Return on Equity (ROE)
-66.83%-50.71%-44.83%-107.50%-121.58%-54.43%
Return on Assets (ROA)
-56.53%-45.38%-40.22%-66.46%-84.49%-49.75%
Return on Capital Employed (ROCE)
-60.96%-48.11%-42.67%-78.75%-99.95%-53.67%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Buyback Yield / Dilution
-13.13%-16.10%-29.55%-60.73%-97.76%0.00%
Total Shareholder Return
-13.13%-16.10%-29.55%-60.73%-97.76%0.00%
SEC Filings: 10-K · 10-Q